Newsflash

LIFT Cancer Trial Starting in China
A new clinical trial based on Dr. Zheng Cui's granulocyte technology is starting at Beijing's 304 Hospital. Go to The LIFT Cancer Treatment Trial Site for more information.
Liver Cancer Treatment Print

Liver cancer is the sixth most commonly diagnosed cancer and the third leading cause of cancer related deaths worldwide.

Liver cancer refers to the growth of malignant tumors in liver tissue. There are two different types of primary liver cancer, heptoma and cholangiocarcinoma. Heptoma or hepatocullular carcinoma (HCC) is the cancer that arises from hepatocytes, the main liver cells. Cholangiocarcinoma, or bile duct cancer, starts in the bile duct cells and grows along the bile ducts in sheets or lines.


Traditional Treatments

Possible traditional treatments are surgery (including liver transplants), chemotherapy, and radiotherapy.

 

Cutting-edge therapies available in China Cancer Center (CCC) for liver cancer may consist of:
For early stage liver cancer
   Surgery
   CIK-DC immunotherapy
Features:
   1. Radical cure for early stage liver cancer.
   2. Efficient prevention of recurrence and metastasis.
   3. No toxicity or side effects to human body.  
   4. Quick recovery after treatments.
   5. Quality of life is improved with an enhanced immune system.


For advanced liver cancer:
   Cryoablation
   Gene therapy
   Antiangionesis therapy
   Interventional therapy
   CIK-DC immunotherapy
Features:
   1. Minimally invasive cryoablation, with little harm to normal function, little pain to patients, small incision wounds, and a quick recovery.
   2. Cryoablation can enhance the therapeutic effects of TACE on large liver tumors.
   3. CIK-DC cell immunotherapy, can improve the immune function against the tumor, which significantly extends survival time with a good quality of life.
   4. No toxicity or side effects. The cutting edge therapies for advanced stage liver cancer offered by CCC removes the lesions as well as improves the immune system. It is a promising treatment to improve overall quality of life and extend survival time.

 

For recurrence and metastatic liver cancer
   Cryoablation
   Gene therapy
   Antiangionesis therapy
   Interventional therapy
   CIK-DC immunotherapy

Metastatic liver cancer is secondary liver cancer. Together with recurrence, metastatic liver cancer usually happens in advanced stages, when the patient is too weak for another surgery or for chemotherapy. Combination of Cryoablation, interventional therapy, and CIK-DC cell immunotherapy is a good systematic treatment for recurrence and metastatic liver cancer.

Read more about cases studies

Colon Cancer w/Liver Metastasis-N/A-70 yrs-Holland-July 2006

Liver Cancer - N/A - 59 yrs - Netherland - Jan. 2005

Liver Cancer - Ms. Yang - 61 yrs - China - April 2003 

Last Updated on Wednesday, 21 July 2010 11:33